New roles for the LKB1→AMPK pathway

被引：215

作者：

Hardie, DG ^{[1
]}

机构：

[1] Univ Dundee, Wellcome Trust Bioctr, Div Mol Physiol, Dundee DD1 4HN, Scotland

来源：

CURRENT OPINION IN CELL BIOLOGY | 2005年 / 17卷 / 02期

基金：

英国惠康基金;

关键词：

D O I：

10.1016/j.ceb.2005.01.006

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The AMP-activated protein kinase(AMPK) is a sensor of cellular energy that is conserved throughout eukaryotes. It is activated by rising AMP, signifying falling energy status caused by starvation for a carbon source or other stress. Binding of AMP to the regulatory gamma subunit triggers phosphorylation of the catalytic a subunit by the upstream kinase LKB1, and the activated kinase switches on ATP-generating catabolic pathways while switching off ATP-requiring processes. AMPK inhibits the TOR (target of rapamycin) pathway by phosphorylating TSC2, thus inhibiting cell growth during times of stress. AMPK is also a target for adipokines that regulate energy balance at the whole-body level.

引用

页码：167 / 173

页数：7

共 53 条

[1] AMP-activated protein kinase plays a role in the control of food intake
Andersson, U
Filipsson, K
Abbott, CR
Woods, A
Smith, K
Bloom, SR
Carling, D
Small, CJ
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) : 12005 - 12008
[2] Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy
Arad, M
Moskowitz, IP
Patel, VV
Ahmad, F
Perez-Atayde, AR
Sawyer, DB
Walter, M
Li, GH
Burgon, PG
Maguire, CT
Stapleton, D
Schmitt, JP
Guo, XX
Pizard, A
Kupershmidt, S
Roden, DM
Berul, CI
Seidman, CE
Seidman, JG
[J]. CIRCULATION, 2003, 107 (22) : 2850 - 2856
[3] Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy
Arad, M
Benson, DW
Perez-Atayde, AR
McKenna, WJ
Sparks, EA
Kanter, RJ
McGarry, K
Seidman, JG
Seidman, CE
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) : 357 - 362
[4] Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD
Baas, AF
Kuipers, J
van der Wel, NN
Batlle, E
Koerten, HK
Peters, PJ
Clevers, HC
[J]. CELL, 2004, 116 (03) : 457 - 466
[5] Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD
Baas, AF
Boudeau, J
Sapkota, GP
Smit, L
Medema, R
Morrice, NA
Alessi, DR
Clevers, HC
[J]. EMBO JOURNAL, 2003, 22 (12) : 3062 - 3072
[6] Regulation of fasted blood glucose by resistin
Banerjee, RR
Rangwala, SM
Shapiro, JS
Rich, AS
Rhoades, B
Qi, Y
Wang, J
Rajala, MW
Pocai, A
Scherer, PE
Steppan, CM
Ahima, RS
Obici, S
Rossetti, L
Lazar, MA
[J]. SCIENCE, 2004, 303 (5661) : 1195 - 1198
[7] The structure of a domain common to archaebacteria and the homocystinuria disease protein
Bateman, A
[J]. TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (01) : 12 - 13
[8] Genome-wide survey of protein kinases required for cell cycle progression
Bettencourt-Dias, M
Giet, R
Sinka, R
Mazumdar, A
Lock, WG
Balloux, F
Zafiropoulos, PJ
Yamaguchi, S
Winter, S
Carthew, RW
Cooper, M
Jones, D
Frenz, L
Glover, DM
[J]. NATURE, 2004, 432 (7020) : 980 - 987
[9] Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy:: evidence for the central role of energy compromise in disease pathogenesis
Blair, E
Redwood, C
Ashrafian, H
Oliveira, M
Broxholme, J
Kerr, B
Salmon, A
Östman-Smith, I
Watkins, H
[J]. HUMAN MOLECULAR GENETICS, 2001, 10 (11) : 1215 - 1220
[10] AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.
Bolster, DR
Crozier, SJ
Kimball, SR
Jefferson, LS
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) : 23977 - 23980

← 1 2 3 4 5 6 →